父母长寿与多发性骨髓瘤及意义未明单克隆丙种球蛋白病患者的生存:一项基于人群的研究
该研究纳入1988至2013年4675例多发性骨髓瘤(MM)患者、6812例意义未明单克隆丙种球蛋白病(MGUS)患者及相应人群对照,评估父母长寿(>90岁)对生存的影响。父母长寿与MM患者死亡风险降低相关(HR=0.92,95%CI 0.84-0.99),也与MGUS患者死亡风险降低相关(HR=0.87,95%CI 0.78-0.96)。仅一方父母长寿时两组死亡风险均显著降低,但双方父母均超过90岁时未达统计学显著。
要点
- 父母长寿(>90岁)与MM患者死亡风险降低相关,HR=0.92(95%CI 0.84-0.99)。
- 父母长寿与MGUS患者死亡风险降低相关,HR=0.87(95%CI 0.78-0.96)。
- 仅一方父母长寿时死亡风险显著降低,双方父母均>90岁时未达统计学显著。
核心结论
- 父母长寿可降低MM和MGUS患者的死亡风险,可能反映宿主遗传和环境因素对生存的重要性。
研究设计与样本
- 基于人群的研究,纳入1988至2013年4675例MM患者、6812例MGUS患者、13398例MM人群对照及19110例MGUS人群对照。
- 长寿定义为年龄>90岁。
主要发现
- MM患者中,父母长寿与死亡风险降低相关(HR=0.92,95%CI 0.84-0.99)。
- MGUS患者中,父母长寿与死亡风险降低相关(HR=0.87,95%CI 0.78-0.96)。
- 仅一方父母长寿时两组死亡风险均显著降低,但双方父母均超过90岁时未达统计学显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Parental longevity is associated with an increased life expectancy; results with regard to specific diseases are conflicting. There are limited data focusing on host characteristics and their effect on survival among multiple myeloma (MM) patients and individuals with monoclonal gammopathy of undetermined significance (MGUS). Therefore, our aim was to evaluate the impact of parental longevity on survival of patients with MM and MGUS. A total of 4675 patients with MM, 6812 MGUS patients and 13 398 population-based controls for MM as well as 19 110 controls for MGUS, from 1988 to 2013, were included in the study. Longevity was defined as >90 years of age. Among MM patients, parental longevity was associated with a decreased risk of death [hazard ratio (HR) = 0·92, 95% confidence interval (CI) 0·84-0·99] and the same was true for MGUS patients (HR = 0·87, 95% CI 0·78-0·96). Having one long lived parent significantly decreased the risk of death in both groups, but was not statistically significant when both parents exceeded 90 years of age. In conclusion, parental longevity decreases the risk of death for patients with MM and MGUS which may reflect the importance of the host's genetic and environmental factors in relation to survival.
引用
- Sverrisdóttir IS, Lund SH, Turesson I, et al. Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study. Br J Haematol. 2019. PMID: 30906990. doi:10.1111/bjh.15883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。